ALISO VIEJO, Calif.
, Jan. 30, 2013 /PRNewswire/ --
Avanir Pharmaceuticals, Inc.
(NASDAQ: AVNR) will report financial results for the quarter ended
December 31, 2012
after market close on
Thursday February 7, 2013
. The company will conduct a conference call and an audio webcast at
1:30 pm Pacific Time
4:30 pm Eastern Time
) on the same day.
Conference Call Information:Domestic callers: 1 (866) 783-2141International callers: +1 (857) 350-1600Passcode: 51423033
Webcast information: Visit
A webcast replay will be available on the Avanir Web site for 30 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1 (888) 286-8010 for domestic callers, or +1 (617) 801-6888 for international callers, and entering reservation code 87153907.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit
AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.
©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.
SOURCE Avanir Pharmaceuticals, Inc.